Ignite Creation Date:
2024-05-06 @ 4:08 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04887519
Status:
COMPLETED
Last Update Posted:
2023-04-18
First Post:
2021-05-13
Brief Title:
A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase ALK Positive Metastatic Non Small Cell Lung Cancer NSCLC
Sponsor:
Organization:
Takeda